Adrian Gottschlich, Veit Bücklein, Karim El-Marouk, Rainer Kaiser, Michael Schmid, Thomas Alexander Janert, Michael Winkelmann, Frank Ziemann, Gerulf Hänel, Stefan Handtke, T Thiele, Christian Wichmann, Sebastian Kobold, Gerhard Zugmaier, Christian Rausch, Hendrik Schulze-Koops, Lars H. Lindner, Karsten Spiekermann, Michael von Bergwelt-Baildon, Marion Subklewe
A CD19-targeted therapy induced remission in a woman with refractory immune thrombocytopenia and antiphospholipid syndrome by stabilizing platelet counts, eliminating pathogenic antibodies, and enabling safer long-term anticoagulation.